J u m p t o c o n t e n t
M a i n m e n u
M a i n m e n u
N a v i g a t i o n
● M a i n p a g e
● C o n t e n t s
● C u r r e n t e v e n t s
● R a n d o m a r t i c l e
● A b o u t W i k i p e d i a
● C o n t a c t u s
● D o n a t e
C o n t r i b u t e
● H e l p
● L e a r n t o e d i t
● C o m m u n i t y p o r t a l
● R e c e n t c h a n g e s
● U p l o a d f i l e
S e a r c h
Search
A p p e a r a n c e
● C r e a t e a c c o u n t
● L o g i n
P e r s o n a l t o o l s
● C r e a t e a c c o u n t
● L o g i n
P a g e s f o r l o g g e d o u t e d i t o r s l e a r n m o r e
● C o n t r i b u t i o n s
● T a l k
( T o p )
1
E a r l y l i f e a n d e d u c a t i o n
2
C a r e e r a n d r e s e a r c h
T o g g l e C a r e e r a n d r e s e a r c h s u b s e c t i o n
2 . 1
A c a d e m i c s e r v i c e
2 . 2
A w a r d s a n d h o n o u r s
3
R e f e r e n c e s
T o g g l e t h e t a b l e o f c o n t e n t s
C l a r e L l o y d
A d d l a n g u a g e s
A d d l i n k s
● A r t i c l e
● T a l k
E n g l i s h
● R e a d
● E d i t
● V i e w h i s t o r y
T o o l s
T o o l s
A c t i o n s
● R e a d
● E d i t
● V i e w h i s t o r y
G e n e r a l
● W h a t l i n k s h e r e
● R e l a t e d c h a n g e s
● U p l o a d f i l e
● S p e c i a l p a g e s
● P e r m a n e n t l i n k
● P a g e i n f o r m a t i o n
● C i t e t h i s p a g e
● G e t s h o r t e n e d U R L
● D o w n l o a d Q R c o d e
● W i k i d a t a i t e m
P r i n t / e x p o r t
● D o w n l o a d a s P D F
● P r i n t a b l e v e r s i o n
A p p e a r a n c e
F r o m W i k i p e d i a , t h e f r e e e n c y c l o p e d i a
Clare Margaret Lloyd FRSB FMedSci is a Professor of Medicine and Vice Dean for Institutional Affairs at Imperial College London . She investigates allergic immunity in early life.[1]
Early life and education
[ edit ]
Lloyd earned her BSc and PhD in immunology at King's College London .[2] She earned her Bachelor's degree in 1987 and her PhD in 1991.[3] She was awarded a National Kidney Research Fund Fellowship and joined the United Medical and Dental Schools of Guy's and St Thomas' Hospitals .[2] Her work considered mouse models of glomerulonephritis . She joined Harvard University to work on chronic inflammatory glomerulonephritis .[2] She became interested in the mechanisms of cell recruitment. She was involved with early studies that looking at the cloning, expression and function of chemokine .[4] Her group demonstrated that T helper cells were the initial responders to CCR3 and CCR4 pathways, but the increase in CCR4 positive cells results in the long-term representation of T helper cells in vivo .[5] LLoyd studied the role of these chemokines in allergic lung inflammation.[6] She looked to better characterise the spatial patterns of chemokine expression to inform therapeutic strategies that limit the side-effects of allergen exposure.[6]
Career and research
[ edit ]
After her postdoctoral fellowship at Harvard University , Lloyd joined at Millennium Pharmaceuticals in 1996 to work on models to characterise novel genes.[2] She returned to the UK in 1999, joining Imperial College London as a Wellcome Trust Senior Fellow.[2] She continued her interest in allergens, looking at the roles for cells and molecules involved in pulmonary inflammation.[2] She is part of the Asthma UK Centre in Allergic Mechanisms of Asthma.[7] She is a member of the British Society for Immunology and Wellcome Trust Infection, Immunity and Immunophenotyping.[8] Lloyd studies the lung cells of children who suffer from asthma and severe wheeze.[9] She has studied why pollen and dust can trigger reactions in some people but not others.[10] She became interested in why exposure to allergens and infections in early life had such an influence on programming pathways to maintain pulmonary homeostasis.[11] [12] She demonstrated that Interleukin 9 can mediate inflammation of asthma.[13]
She was appointed Professor in Respiratory Immunology in 2006.[2] She is co-lead of the respiratory division.[14] Her research group, the Lloyd Lab , look at the interactions between lung cells and infiltrating inflammatory cells.[15] Lloyd was awarded the Imperial College London Rectors Medal for her Research Supervision in 2014.[16] In 2018, she demonstrated that the ICOS/ICOS‐L pathway could be a therapeutic target in asthma.[17]
Academic service
[ edit ]
She was the lead National Heart and Lung Institute Athena Swan lead between 2009 and 2014, achieving the first Silver award for a medical department in the UK.[18] She pushed for the improvement of the Imperial College London mentoring scheme, in an effort to support early career researchers.[18] In 2016 she was appointed Dean of Institutional Affairs at Imperial College London .[18] She serves on the scientific advisory board of Science Magazine and is an editor of Nature Mucosal Immunology and the European Journal of Immunology .[19] [20] [21] She serves on the Royal Society Newton International Fellowships board.[22]
Awards and honours
[ edit ]
References
[ edit ]
^ ORCID 0000-0001-8977-6726
^
^ Lloyd, Clare M.; Delaney, Tracy; Nguyen, Trang; Tian, Jane; Martinez-A, Carlos; Coyle, Anthony J.; Gutierrez-Ramos, Jose-Carlos (2000). "Cc Chemokine Receptor (Ccr)3/Eotaxin Is Followed by Ccr4/Monocyte-Derived Chemokine in Mediating Pulmonary T Helper Lymphocyte Type 2 Recruitment after Serial Antigen Challenge in Vivo" . The Journal of Experimental Medicine . 191 (2 ): 265–274. doi :10.1084/jem.191.2.265 . ISSN 0022-1007 . PMC 2195756 . PMID 10637271 .
^ a b Lloyd, Clare (2002). "Chemokines in allergic lung inflammation" . Immunology . 105 (2 ): 144–154. doi :10.1046/j.1365-2567.2002.01344.x . ISSN 0019-2805 . PMC 1782646 . PMID 11872089 .
^ "Prof. Clare Lloyd | Asthma UK Centre" . asthma-allergy.ac.uk . Retrieved 2018-12-16 .
^ "Home | 3i Consortium - Wellcome Trust Sanger Institute" . immunophenotype.org . Retrieved 2018-12-16 .
^ "Wheezing and Asthma: Earlier Diagnosis and Treatment | Action Medical Research | Children's Charity" . action.org.uk . 2013-04-10. Archived from the original on 2018-12-17. Retrieved 2018-12-16 .
^ "Lungs" . Wellcome Collection . Retrieved 2018-12-16 .
^ Lloyd, Clare M.; Saglani, Sejal (2010). "Asthma and allergy: The emerging epithelium" . Nature Medicine . 16 (3 ): 273–274. doi :10.1038/nm0310-273 . PMC 3380503 . PMID 20208514 .
^ Lloyd, Clare M.; Hawrylowicz, Catherine M. (2009). "Regulatory T Cells in Asthma" . Immunity . 31 (3 ): 438–449. doi :10.1016/j.immuni.2009.08.007 . ISSN 1074-7613 . PMC 3385348 . PMID 19766086 .
^ Lloyd, Clare M.; Phimister, Elizabeth G.; Harker, James A. (2018). "Epigenetic Control of Interleukin-9 in Asthma" (PDF) . New England Journal of Medicine . 379 (1 ): 87–89. doi :10.1056/NEJMcibr1803610 . hdl :10044/1/61609 . ISSN 0028-4793 . PMID 29972761 . S2CID 49651778 .
^ "Structure and key people" . Imperial College London . Retrieved 2018-12-16 .
^ "People – LLOYD LAB" . Retrieved 2018-12-16 .
^ "Honours and Memberships - Professor Clare Lloyd" . imperial.ac.uk . Retrieved 2018-12-16 .
^ Uwadiae, Faith I.; Pyle, Chloe J.; Walker, Simone A.; Lloyd, Clare M.; Harker, James A. (2018). "Targeting the ICOS/ICOS-L pathway in a mouse model of established allergic asthma disrupts T follicular helper cell responses and ameliorates disease" . Allergy . 74 (4 ): 650–662. doi :10.1111/all.13602 . ISSN 1398-9995 . PMC 6492018 . PMID 30220084 .
^ a b c "Professor Clare Lloyd on being Vice Dean (Institutional Affairs)" . FoM Staff Blog . 2017-11-27. Retrieved 2018-12-16 .
^ "Advisory Board" . Science | AAAS . 2018-01-31. Retrieved 2018-12-18 .
^ "About the Editors | Mucosal Immunology" . www.nature.com . Retrieved 2018-12-18 .
^ "European Journal of Immunology" . onlinelibrary.wiley.com . doi :10.1002/(ISSN)1521-4141 . hdl :2027.42/37955 . S2CID 250212720 . Retrieved 2018-12-18 .
^ "Clare Lloyd | Royal Society" . royalsociety.org . Retrieved 2018-12-18 .
^ "Professor Clare Lloyd | The Academy of Medical Sciences" . acmedsci.ac.uk . Retrieved 7 March 2020 .
International
National
Academics
R e t r i e v e d f r o m " https://en.wikipedia.org/w/index.php?title=Clare_Lloyd&oldid=1136119808 "
C a t e g o r i e s :
● L i v i n g p e o p l e
● W o m e n i m m u n o l o g i s t s
● B r i t i s h i m m u n o l o g i s t s
● A l u m n i o f K i n g ' s C o l l e g e L o n d o n
● A c a d e m i c s o f I m p e r i a l C o l l e g e L o n d o n
● H a r v a r d U n i v e r s i t y f a c u l t y
● F e l l o w s o f t h e A c a d e m y o f M e d i c a l S c i e n c e s ( U n i t e d K i n g d o m )
● F e l l o w s o f t h e R o y a l S o c i e t y o f B i o l o g y
● B r i t i s h w o m e n s c i e n t i s t s
H i d d e n c a t e g o r i e s :
● A r t i c l e s w i t h s h o r t d e s c r i p t i o n
● S h o r t d e s c r i p t i o n m a t c h e s W i k i d a t a
● A r t i c l e s w i t h h C a r d s
● A l l a r t i c l e s w i t h v a g u e o r a m b i g u o u s t i m e
● V a g u e o r a m b i g u o u s t i m e f r o m D e c e m b e r 2 0 1 8
● A r t i c l e s w i t h V I A F i d e n t i f i e r s
● A r t i c l e s w i t h W o r l d C a t E n t i t i e s i d e n t i f i e r s
● A r t i c l e s w i t h J 9 U i d e n t i f i e r s
● A r t i c l e s w i t h L C C N i d e n t i f i e r s
● A r t i c l e s w i t h G o o g l e S c h o l a r i d e n t i f i e r s
● A r t i c l e s w i t h O R C I D i d e n t i f i e r s
● Y e a r o f b i r t h m i s s i n g ( l i v i n g p e o p l e )
● T h i s p a g e w a s l a s t e d i t e d o n 2 8 J a n u a r y 2 0 2 3 , a t 2 1 : 0 3 ( U T C ) .
● T e x t i s a v a i l a b l e u n d e r t h e C r e a t i v e C o m m o n s A t t r i b u t i o n - S h a r e A l i k e L i c e n s e 4 . 0 ;
a d d i t i o n a l t e r m s m a y a p p l y . B y u s i n g t h i s s i t e , y o u a g r e e t o t h e T e r m s o f U s e a n d P r i v a c y P o l i c y . W i k i p e d i a ® i s a r e g i s t e r e d t r a d e m a r k o f t h e W i k i m e d i a F o u n d a t i o n , I n c . , a n o n - p r o f i t o r g a n i z a t i o n .
● P r i v a c y p o l i c y
● A b o u t W i k i p e d i a
● D i s c l a i m e r s
● C o n t a c t W i k i p e d i a
● C o d e o f C o n d u c t
● D e v e l o p e r s
● S t a t i s t i c s
● C o o k i e s t a t e m e n t
● M o b i l e v i e w